How should I manage a patient with retro‑orbital pain, blurred vision, mild dizziness, and headache who has been overusing Excedrin (acetaminophen/aspirin/caffeine)?

Immediately Stop Excedrin and Transition to Appropriate Migraine Management

This patient has medication overuse headache (MOH) from Excedrin and requires immediate cessation of the overused medication, initiation of migraine prophylaxis, and education about proper acute treatment strategies. The retro-orbital pain, blurred vision, and headache pattern are consistent with chronic migraine complicated by medication overuse 1.

Critical First Step: Address Medication Overuse

Stop Excedrin immediately. The patient is experiencing medication overuse headache, defined as headache occurring ≥15 days per month for at least 3 months in someone with pre-existing headache disorder who takes combination analgesics (like Excedrin) on ≥10 days per month 1. The threshold for MOH with combination analgesics containing caffeine is lower than simple analgesics, making this particularly problematic 1.

Withdrawal Management

• Abrupt withdrawal is recommended for combination analgesics like Excedrin (aspirin/acetaminophen/caffeine) 2, 3
• Outpatient withdrawal is appropriate unless the patient has been overusing opioids or benzodiazepines (which would require inpatient management) 3
• Treat withdrawal symptoms with:
  • Prednisone 60mg daily for 5-7 days 3
  • Antiemetics (metoclopramide or prochlorperazine) as needed for nausea 1, 4

Initiate Migraine Prophylaxis Immediately

Start prophylactic medication on day 1 of withdrawal or even before stopping Excedrin 3. The 2025 ACP guidelines and recent evidence support several options:

First-Line Prophylaxis Options:

• Topiramate up to 200mg (moderate evidence specifically for chronic migraine with medication overuse) 3
• CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab) - effective in chronic migraine with medication overuse 5, 2
• Amitriptyline 25-50mg at bedtime (possibly effective for withdrawal symptoms and prophylaxis) 3

Choose topiramate or a CGRP antibody as first-line given the medication overuse context 2, 3.

Establish Proper Acute Treatment Protocol

Once withdrawal is complete and prophylaxis initiated, educate the patient on appropriate acute treatment:

For Future Migraine Attacks:

• Limit acute medication use to <10 days per month to prevent recurrence of MOH 1
• First-line acute treatment: Triptan + NSAID combination (e.g., sumatriptan 100mg + naproxen 500mg) 1
• Alternative if triptans contraindicated: CGRP antagonist (gepant) like ubrogepant or rimegepant 1
• Treat early in the attack for maximum efficacy 1

Critical Pitfall to Avoid:

Do NOT prescribe butalbital-containing medications or opioids - these are explicitly contraindicated for episodic migraine and carry high risk of MOH recurrence 1.

Address the Visual Symptoms

The blurred vision and retro-orbital pain warrant brief consideration:

• These symptoms are consistent with migraine with or without aura
• However, if this represents new-onset visual symptoms or neurologic changes, perform a focused neurologic examination looking for papilledema, visual field defects, or focal deficits
• Normal exam supports migraine diagnosis; abnormal findings require neuroimaging

Follow-Up Strategy

Schedule close follow-up to prevent relapse:

• Week 2-4: Assess withdrawal symptoms and prophylaxis tolerability
• Month 3: Evaluate headache frequency reduction
• Month 6-12: Long-term monitoring (success rate 50-70% at this timeframe) 2

Relapse prevention education:

• Explain the 10-day-per-month rule for acute medications
• Emphasize lifestyle modifications: hydration, regular meals, consistent sleep, aerobic exercise, stress management 1
• Consider behavioral interventions or physical therapy as adjuncts 5

The success of this approach depends on patient understanding that Excedrin, while temporarily helpful, is perpetuating and worsening the headache disorder 2, 6.